コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 conversion of which is catalysed by the Pin1 prolyl isomerase.
2 Rhodanese-like domain homologous to that of prolyl isomerase.
3 on in some proteins is catalysed by the Pin1 prolyl isomerase.
4 interaction with Pin1, a member of peptidyl-prolyl isomerase.
5 (3)) to catalysis by cyclophilin, a peptidyl-prolyl isomerase.
6 ce of human and periplasmic E. coli peptidyl-prolyl isomerase.
7 from the sensitivity of its rate to peptidyl prolyl isomerase.
8 e-specific binding protein and a nonspecific prolyl isomerase.
9 investigated the folding kinetics of FKBP, a prolyl isomerase.
10 D (Cyp-D) is a mitochondrial matrix peptidyl-prolyl isomerase.
11 a ubiquitously expressed cis-trans peptidyl-prolyl isomerase.
12 lding kinetics in the presence of a peptidyl prolyl isomerase.
13 by increased expression of Pin1, a peptidyl-prolyl isomerase.
14 erentiated ligands of human Pin1, a peptidyl-prolyl isomerase.
15 pregulation of other chaperones and peptidyl-prolyl isomerases.
16 gnaling since cyclophilins are also peptidyl-prolyl isomerases.
17 ns, is accelerated by the action of peptidyl-prolyl isomerases.
18 urA are the four known periplasmic cis-trans prolyl isomerases.
19 g experiments, and is unaffected by peptidyl-prolyl isomerases.
20 her is prevented by an inhibitor of peptidyl-prolyl isomerases.
21 embers of the cyclophilin family of peptidyl-prolyl isomerases.
22 nuclease T1, whose folding is accelerated by prolyl isomerases.
23 of prolyl residues, a reaction catalyzed by prolyl isomerases.
24 equired for an interaction with the peptidyl prolyl isomerase 1 (Pin1), a critical component of PDPK-
27 Da FK506-binding protein (also known as FKBP prolyl isomerase 1A), regulates the neuronal resilience
29 lymorphisms (SNPs) in the region of peptidyl-prolyl isomerase A (PPIA) that encodes CypA on HCV infec
30 iquitous peptidyl prolyl isomerase, peptidyl prolyl isomerase A (PPIA), concentrates inside liquid-li
32 report that in addition to its known histone prolyl isomerase activities, the Fpr4 FKBP domain binds
33 tant enzymes exhibited substantial levels of prolyl isomerase activity (5-20% of wild-type), revealin
35 the folding of type III collagen through its prolyl isomerase activity and acted as a molecular chape
36 Although all immunophilins possess peptidyl-prolyl isomerase activity and are identified from a wide
37 important in protein folding, because TF has prolyl isomerase activity and associates with nascent po
39 mically that the CTD possesses weak peptidyl-prolyl isomerase activity and show that the active-site
40 m of action of CyPA is likely to involve its prolyl isomerase activity because a mutant CyPA with a s
42 tant role for CyPA and enzymes with peptidyl-prolyl isomerase activity in the pathogenesis of vascula
43 e mutant enzymes had little or no detectable prolyl isomerase activity in the standard peptide substr
51 how that rapamycin, a drug that inhibits the prolyl isomerase activity of FKBP and dissociates FKBP f
53 2A show reciprocal genetic interactions, and prolyl isomerase activity of Pin1 is essential for cell
55 ecombinant TvCyP1 exhibited typical peptidyl-prolyl isomerase activity with kcat/Km of approximately
56 at SurA, a periplasmic protein with peptidyl-prolyl isomerase activity, is involved in the maturation
57 (CyP A), a cellular chaperone with cis-trans prolyl isomerase activity, is required for postassembly
63 chaperone with remarkable properties: it has prolyl-isomerase activity, associates with nascent polyp
64 alled Ppif), a mitochondrial matrix peptidyl prolyl isomerase and apoptosis regulator, results in inc
66 live in extreme polar environments: the Ess1 prolyl isomerase and its target, the carboxy-terminal do
67 es a homologue of Trigger Factor, a peptidyl-prolyl isomerase and putative chaparone which is highly
69 rther show interactions between the peptidyl-prolyl isomerase and Trp-Trp (WW) domains amplify the co
72 cascade involving GSK3beta kinase, the Pin1 prolyl isomerase, and the PP2A-B56alpha phosphatase cont
73 Calstabin2, an 11.8-kDa cis-trans peptidyl-prolyl isomerase (apparent molecular mass 12.6 kDa), sta
75 ozygous start-codon mutation in the peptidyl-prolyl isomerase B gene (PPIB), which results in a lack
77 widely distributed cyclophilin and peptidyl-prolyl isomerase, could inhibit c-Myb DNA binding activi
79 ration into virions of the cellular peptidyl-prolyl isomerase cyclophilin A (CyPA) by the Gag polypro
82 h sequence, whose interaction with the human prolyl isomerase cyclophilin A (CypA) is essential for v
83 HIV-1 specifically incorporates the peptidyl prolyl isomerase cyclophilin A (CyPA), the cytosolic rec
84 ifically incorporates the host cell peptidyl-prolyl isomerase cyclophilin A into virions via contacts
86 in a manner similar to that of the peptidyl-prolyl isomerase cyclophilin A, we probed purified virio
88 ecular Cell reveals a role for the host cell prolyl isomerase cyclophilin B (CyPB) in the replication
89 he interaction between ANT3 and the peptidyl-prolyl isomerase cyclophilin D (CypD), mortalin decrease
90 tic depletion of the mitochondrial cis-trans prolyl isomerase cyclophilin D as in wild-type cells, in
92 ls that silencing the mitochondrial peptidyl prolyl isomerase cyclophilin-D (Cyp-D) reduces Vo(2).
94 ssential interaction with the human peptidyl prolyl isomerase, cyclophilin A (CypA), that results in
95 ening, by testing the effect of the peptidyl-prolyl isomerase, cyclophilin A, on the CFTR channel.
98 s-induced cytosolic chaperone PPID (peptidyl-prolyl isomerase D/cyclophilin 40/Cyp40) drives OMM inse
99 receptors, red/green opsins, upon cis-trans prolyl isomerase-dependent and direct modification of op
100 and contains two domains, an amino-terminal prolyl isomerase domain and a carboxy-terminal tetratric
102 ter function was dependent upon the peptidyl-prolyl isomerase domain of RopA and mutants that lacked
103 sA reveals a central catalytic parvulin-type prolyl isomerase domain, which is inserted into a larger
104 cyclophilin B, which contained its peptidyl-prolyl isomerase domain; this cyclophilin fragment repre
105 506-binding protein with an inactive peptide prolyl-isomerase domain that binds DOUBLETIME and tetrat
111 showed previously that the WW domain of the prolyl isomerase, Ess1, can bind the phosphorylated carb
113 bitors synergized with inhibitors of PIN1, a prolyl isomerase essential for IRAK1 activation in respo
125 hilins, which are a large family of cellular prolyl isomerases, have been found to inhibit Tomato bus
126 ulated by the cyclophilin family of peptidyl-prolyl isomerases, highlighting the potential for regula
127 , while surA encodes a periplasmic cis-trans prolyl isomerase important in the biogenesis of outer me
130 zymes such as Cyp-40, and implicate peptidyl-prolyl isomerases in the regulation of transcription, tr
131 st protein cyclophilin A (CypA), a cis-trans prolyl isomerase, in some way seems to assist in this as
133 slower phase of P117G SNase are catalyzed by prolyl isomerase, indicating that proline isomerization
134 ancement in binding affinity (>40 fold), and prolyl isomerase inhibition (PPIase) activity (>200 fold
139 deficiency, the activity of Pin1, a peptidyl-prolyl isomerase, is reduced (see the related article be
141 ion, the cis/trans equilibrium, catalyzed by prolyl isomerases, is shifted towards trans, while stead
143 pif gene) is a mitochondrial matrix peptidyl-prolyl isomerase known to modulate opening of the mitoch
144 encoding the spliceosome components Peptidyl-Prolyl Isomerase Like-1 (PPIL1) or Pre-RNA Processing-17
145 and cyclophilin D (the Ppif gene product), a prolyl isomerase located within the mitochondrial matrix
146 function and indicate that the inhibition of prolyl isomerases may be a novel therapeutic strategy in
150 little is known about the impact of peptidyl prolyl isomerases on the LLPS of IDPs, which often conta
152 emonstrate that the most ubiquitous peptidyl prolyl isomerase, peptidyl prolyl isomerase A (PPIA), co
155 iquitination and degradation mediated by the prolyl isomerase Pin1 and the ubiquitin ligase KLHL20.
159 gard, it has been recently observed that the prolyl isomerase Pin1 can interact with proteins phospho
165 mics to identify a homologue of the peptidyl-prolyl isomerase PIN1 in T. annulata (TaPIN1) that is se
166 we investigated the globular folded peptidyl-prolyl isomerase Pin1 in Xenopus laevis oocytes and in n
171 We have previously shown that the peptidyl-prolyl isomerase Pin1 is able to affect cell proliferati
174 athways and a unique therapeutic target, the prolyl isomerase Pin1 is overexpressed in a majority of
176 Previously we reported that the peptidyl prolyl isomerase Pin1 modulates RNAP II function during
178 re we report that chemical inhibition of the prolyl isomerase Pin1 or downregulation of Pin1 by small
179 igration was suppressed by inhibitors of the prolyl isomerase Pin1 or extracellular signal-regulated
181 ic LIC1-CTD phosphorylation also engages the prolyl isomerase Pin1 predominantly to Hook2-dynein-Nde1
185 phosphorylated proteins is regulated by the prolyl isomerase Pin1 through isomerization of phosphory
188 exhibited increased binding of p66(Shc) with prolyl isomerase Pin1, a protein implicated in transloca
189 and stability of proteins is mediated by the prolyl isomerase Pin1, but the role of Pin1 in the heart
190 omotes the interaction between Nanog and the prolyl isomerase Pin1, leading to Nanog stabilization by
191 n by ERK, conformation of XPO5 is altered by prolyl isomerase Pin1, resulting in reduction of pre-miR
193 -mediated up-regulation of the expression of prolyl isomerase PIN1, which in turn increases enzyme ac
214 monstrate that the phosphorylation-dependent prolyl-isomerase Pin1 interacts with ADAR2 and is a posi
216 tively regulated by the interaction with the prolyl-isomerase Pin1, via proteasome-mediated degradati
217 that Notch3 is a novel target protein of the prolyl-isomerase Pin1, which is able to regulate Notch3
222 118-ERalpha) is a substrate for the peptidyl prolyl isomerase, Pin1, which mediates cis-trans isomeri
225 oliferation and due to its specific peptidyl-prolyl-isomerase (PPI) function, the FKBP protein family
226 ition of MLK3 down-regulates expression of a prolyl-isomerase, Ppia, which is directly phosphorylated
227 e repeat (TPR) domain and catalyzes peptidyl-prolyl isomerase (PPIase) activity during folding of kin
231 inct functional roles for the PrsA2 peptidyl-prolyl isomerase (PPIase) and the N- and C-terminal doma
234 (WW) domain flexibly tethered to a peptidyl-prolyl isomerase (PPIase) domain, resulting in interdoma
235 ophilins harbors the characteristic peptidyl-prolyl isomerase (PPIase) domain, whereas three copies o
237 that small molecule ligands for the peptidyl-prolyl isomerase (PPIase) FKBP12 possess powerful neurop
240 of TGF-beta1 and show here that the peptidyl-prolyl isomerase (PPIase) Pin1 promoted the stability of
241 The Escherichia coli periplasmic peptidyl-prolyl isomerase (PPIase) SurA is involved in the matura
242 Cyclophilin A (CypA/Ppia) is a peptidyl-prolyl isomerase (PPIase) that binds the immunosuppressi
244 an essential and conserved mitotic peptidyl-prolyl isomerase (PPIase) that is distinct from members
245 utation in a novel highly conserved peptidyl prolyl isomerase (PPIase) that selectively eliminates Rb
248 small-molecule ligands for the peptidyl and prolyl isomerases (PPIase) of FKBP12 have been shown to
252 06-binding protein (FKBP) family of peptidyl-prolyl isomerases (PPIases) is characterized by a common
255 rent families of enzymes, known as "peptidyl-prolyl isomerases" (PPIases), catalyze this reaction, wh
258 he genes encoding SpeB (speB) and a peptidyl-prolyl isomerase (prsA) constitute an operon with transc
259 fectants suggest the involvement of peptidyl-prolyl isomerase, Raf kinase inhibitor and 80 kDa protei
262 Here, we report that cyclophilin B (CypB), a prolyl isomerase residing in the endoplasmic reticulum (
265 on of ribonuclease T1 in the presence of the prolyl isomerase SlyD from Escherichia coli to examine h
267 cored by the ubiquitous presence of peptidyl prolyl isomerases such as cyclophilins that accelerate t
268 of cyclophilin A (CypA), a cellular peptidyl-prolyl isomerase that binds specifically to CA, was decr
272 s, rapamycin forms complexes with the FKBP12 prolyl isomerase that block cell cycle progression by in
274 covalent agents targeting Pin1, a cis-trans prolyl isomerase that plays a crucial role in tumorigene
277 D (CypD) is a mitochondrial matrix peptidyl-prolyl isomerase that regulates the MPTP and is a drug t
279 o a large family of enzymes called "peptidyl prolyl isomerases" that assist protein folding and assem
280 ollagen a trimerization domain and cis-trans prolyl isomerases to facilitate and accelerate triple he
281 utions of the cyclophilin subset of peptidyl-prolyl isomerases to protein folding and identified cycl
282 of immunophilins, which function as peptidyl-prolyl isomerases, to regulate Crk proteins in human T l
283 an inhibitor of the FKBP family of peptidyl prolyl isomerases, was shown to increase survival in ani
284 e formation of disulfide bonds; and peptidyl-prolyl isomerase-were immobilized on an agarose gel.
285 ude protein disulfide isomerase and peptidyl prolyl isomerase, which catalyze the rearrangement of di
286 t class of molecular chaperones are peptidyl prolyl isomerases, which enhance the cis/trans-isomeriza
287 feedback sites or overexpression of the Pin1 prolyl-isomerase, which facilitates B-Raf dephosphorylat